Followers

AstraZeneca breast cancer drug Lynparza is approved by EU regulators

AstraZeneca breast cancer drug Lynparza is approved by EU regulators
Lynparza has been approved by the European Commission to treat patients suffering from a type of high-risk, early-stage breast cancer.

* This article was originally published here

Comments

Popular posts from this blog

Politicians are wrong about what the public want

Federal Suit Hits Soros for $10 Billion for ‘Political Meddling, Motivated Solely by Malice’

Furious Brussels tells EU states to ignore UK as huge trade deal erupts